Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Jan 30, 2013 (14 years ago)

BroveX PSE DM

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: Products are underdosed or have an incorrect dosage regime.

Cause type: Wrong potency / content

Sub- or super-potent product, or a failed content-uniformity / assay test. You may receive too little or too much active ingredient - a direct dosing risk. All wrong potency / content recalls.

What was recalled

BroveX PSE DM, Antihistamine, Cough Suppressant, Decongestant, 100 count bottle, OTC, Manufactured for: Pernix Therapeutics, Gonzales, LA 70737 NDC 58605-441-01

Affected NDC 58605-0441-01

Compare with the code on your package — it is the most precise check available.

Drug: Histamine

Recalling firm
TG United, Inc.
NDC code
58605-441-01
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-525-2013 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Histamine recalls

See all
Class II · Moderate risk

AbeeMed cream

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Terminated Stability / shelf life Pharma-Natural Inc. D-1493-2019
Class II · Moderate risk

Histamine Phosphate active pharmaceutical ingredient packaged in…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-706-2015
Class II · Moderate risk

Histamine Diphosphate active pharmaceutical ingredient packaged…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-705-2015

Other recalls by TG United, Inc.

All 2013 recalls
Class II · Moderate risk

ZoDen PD

CGMP Deviations: Products are underdosed or have an incorrect dosage regime.

Terminated Wrong potency / content TG United, Inc. NDC 13811-0073-16 D-546-2013
Class II · Moderate risk

ZoDen DM Drops

CGMP Deviations: Products are underdosed or have an incorrect dosage regime.

Terminated Wrong potency / content TG United, Inc. NDC 13811-0080-30 D-545-2013
Class II · Moderate risk

Z-Dex Syrup

CGMP Deviations: Products are underdosed or have an incorrect dosage regime.

Terminated Wrong potency / content TG United, Inc. NDC 13811-0002-16 D-544-2013